FORESEE GENOMICS

Making advanced genetic testing accessible to every lab.

Sector: Genomics / Life Sciences

Focus: Next-Generation Sequencing

Customer: Small & Medium-Sized Laboratories

Status: Active

Foresee Genomics is developing next-generation sequencing solutions designed to allow small and medium-sized laboratories to bring advanced genomic testing capabilities in-house. Its platform combines molecular kits, Nanopore sequencing, protocols, reagents, and bioinformatics software with the goal of making high-precision genomic analysis faster, simpler, and more economical.

The YBUK Perspective

Expanding access to a powerful technology

Next-generation sequencing has historically required meaningful infrastructure, technical expertise, and scale. Foresee is working to lower those barriers, enabling smaller laboratories to perform sophisticated genetic analyses with less infrastructure, smaller sample requirements, and lower costs.

Experienced industry leadership

Foresee is led by a team with backgrounds spanning genomics, clinical genetics, bioinformatics, medical technology, software development, and commercialization. Founder and CTO Roi Feingersch has experience developing genomic tests for cancer and genetic diseases, while the broader team brings decades of relevant scientific and commercial experience.

A large, evolving end market

As genomic information becomes increasingly important to precision medicine, Foresee is building the tools to broaden access to sequencing capabilities beyond large centralized laboratories. Its model is designed to give smaller labs greater independence while creating new opportunities to offer advanced genetic testing.

We are drawn to businesses that make sophisticated capabilities simpler and more accessible. Foresee reflects several qualities we look for at YBUK: experienced operators, proprietary know-how, an expanding end market, and a business model built around solving a meaningful customer constraint. Rather than asking smaller laboratories to fundamentally change how they operate, Foresee is developing a way for them to add advanced sequencing capabilities within their existing businesses.

Foresee Genomics products are currently for Research Use Only and are not for use in diagnostic procedures.